The need for continuing provision of beneficial experimental interventions after research is concluded remains a controversial topic in bioethics for research. Based on the principle of beneficence, justice as reciprocity, concerns about exploitation and fair benefits, participants should be able to have continuing access to benefits beyond the research period. However, there is no consensus about whether or not post-trial provision of beneficial interventions should be mandatory for participants from developing countries. This paper summarises recommendations from international and national guidelines. Ethical principles and practical issues relating to post-trial provision are also discussed. In conclusion, post-trial provision is not necessary in all situations and a set of criteria are proposed to identify the situations that beneficial interventions should be provided beyond the research period. However, mandatory post-trial supply of beneficial experimental interventions should be assured for those who still need and are able to benefit from them but have no alternative access. Mandatory provision is based on universal bioethical principles such as beneficence and justice. Furthermore, difficulties associated with implementation of post-trial provision are not unmanageable. Careful advanced planning and a comprehensive partnership among relevant parties would be very helpful in solving these difficulties in practice, which therefore should not be taken as an excuse to escape post-trial responsibility.
- developing countries
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests: None.
Read the full text or download the PDF:
Other content recommended for you
- WHO guidance on ethics in outbreaks and the COVID-19 pandemic: a critical appraisal
- Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach
- Can one do good medical ethics without principles?
- Composition, training needs and independence of ethics review committees across Africa: are the gate-keepers rising to the emerging challenges?
- Principles of justice in health care rationing
- Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS)
- Ethical issues in funding research and development of drugs for neglected tropical diseases
- Op GRITROCK ethics; the way of things to come?
- Will international human rights subsume medical ethics? Intersections in the UNESCO Universal Bioethics Declaration
- Ethical dilemmas in palliative care in traditional developing societies, with special reference to the Indian setting